ALAMEDA, Calif., Jan. 15, 2026 /PRNewswire/ — Penumbra, Inc. (NYSE:PEN), the world’s leading thrombectomy company, today announced certain unaudited and preliminary financial results for the fourth quarter and full year 2025.
…